Skip to content

Clinical Observation and Mechanism Study of Qinghua Xiaoyong Formula in Treating Perianal Abscess

Clinical Observation and Mechanism Study of Qinghua Xiaoyong Formula in Treating Perianal Abscess

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000424
Enrollment
Unknown
Registered
2025-02-27
Start date
2024-03-20
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perianal Abscess

Interventions

Antibiotics group:Oral administration of Cefdinir for 5 days, 0.1g per dose, 3 times a day.
TCM group:Oral administration of Qinghua Xiaoyong Formula for 2 weeks twice a day 1 packet per dose.

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with perianal abscess who meet the above diagnostic criteria; 2. Aged 18 to 70 years regardless of gender; 3. Willing to undergo incision and drainage surgery; 4. Perianal abscess with an abscess cavity size between 4 cm³ and 32 cm³ and the deepest part not exceeding 5 cm above the anal margin excluding horseshoe-shaped abscesses; 5. Willing to receive oral traditional Chinese medicine treatment; 6. Voluntarily participate in this trial and sign an "Informed Consent Form."

Exclusion criteria

Exclusion criteria: 1. Allergic to cephalosporin antibiotics or related traditional Chinese medicines; 2. Used any antibiotics within one week prior to inclusion; 3. Suffering from infections at other sites during the treatment period; 4. A history of anal and rectal surgery; 5. Diagnosed with diabetes inflammatory bowel disease tuberculosis HIV/AIDS immunodeficiencies or other conditions that affect wound healing; 6. Pregnant or breastfeeding women; 7. Suffering from mental disorders.

Design outcomes

Primary

MeasureTime frame
Reduction rate of inflammatory infiltration area;

Secondary

MeasureTime frame
stool characteristics and frequency;fever;IL-6;IL-1ß;CRP;Gut Microbiota;Fistula formation status;ESR;TNF-a;Wound healing time;White Blood Cell Count;Neutrophil Count;IL-8;quality of life score;wound exudate score;PCT;pain;

Countries

China

Contacts

Public ContactFang Chenyang

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

303464950@qq.com+86 150 2665 3599

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026